CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies
California refocusing spending priorities, dollars likely to go in different directions
For patients, researchers and policymakers, the next three days mark the beginning of a key, new “adventure” in the gene and stem cell therapy world of the $12 billion California Instit…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.